Profile data is unavailable for this security.
About the company
Chr Hansen Holding A/S is a Denmark-based bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The Company’s business is divided into three divisions, namely Food Cultures & Enzymes, Health & Nutrition and Natural Colors. The Food Cultures & Enzymes division develops and produces cultures, enzymes and probiotics for the food industry in general and the dairy industry in particular. The Health & Nutrition division develops, produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula and animal feed industries. The Natural Colors division develops and supplies natural color solutions to the food and beverage industry, in particular the beverage, confectionery, ice cream, dairy, fruit preparation and prepared food segments. The Company operates in Europe, North and South America, as well as Asia Pacific, Middle East and Africa.
- Revenue in DKK (TTM)8.52bn
- Net income in DKK1.65bn
- Incorporated2004
- Employees3.95k
- LocationChr Hansen Holding A/SBoege Alle 10-12HOERSHOLM 2970DenmarkDNK
- Phone+45 45747474
- Fax+45 45748888
- Websitehttps://www.chr-hansen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson Matthey PLC | 152.04bn | 1.35bn | 38.13bn | 13.56k | 29.79 | 1.71 | 12.28 | 0.2508 | 0.7922 | 0.7922 | 89.55 | 13.81 | 2.18 | 7.90 | 8.77 | 1,274,336.00 | 1.93 | 5.37 | 3.78 | 8.39 | 6.80 | 7.56 | 0.8854 | 2.46 | 0.7791 | 8.64 | 0.3507 | 45.20 | 7.52 | 7.90 | -19.61 | -9.25 | 8.49 | -0.7396 |
| Azelis Group | 21.04bn | 504.19m | 40.20bn | 3.18k | 79.73 | 2.43 | 41.68 | 1.91 | 0.2897 | 0.2897 | 12.09 | 9.53 | -- | -- | -- | 889,926.00 | -- | -- | -- | -- | 22.70 | -- | 2.48 | -- | 0.8493 | 2.49 | 0.3102 | -- | 27.19 | -- | -4.52 | -- | -- | -- |
| Clariant AG | 28.53bn | 874.16m | 43.45bn | 13.06k | 49.59 | 2.62 | 14.63 | 1.52 | 0.3654 | 2.50 | 11.95 | 6.91 | 0.5251 | 3.94 | 6.22 | 298,375.50 | 1.97 | 2.05 | 2.77 | 2.96 | 30.89 | 30.82 | 3.75 | 3.27 | 0.8177 | 13.56 | 0.4635 | 206.68 | -12.25 | -7.84 | 261.40 | -15.77 | -5.70 | -- |
| Imcd NV | 25.56bn | 1.54bn | 57.86bn | 3.74k | 37.48 | 5.32 | 25.91 | 2.26 | 3.64 | 3.64 | 60.35 | 25.64 | 1.15 | 6.02 | 6.31 | 918,516.10 | 6.95 | 5.64 | 9.71 | 7.82 | 21.38 | 20.28 | 6.03 | 4.65 | 0.81 | 14.84 | 0.4334 | 44.47 | 23.80 | 14.91 | 72.55 | 23.22 | 23.72 | 24.12 |
| Oci NV | 53.04bn | 6.21bn | 58.63bn | 3.72k | 9.45 | 3.14 | 3.25 | 1.11 | 3.96 | 3.96 | 33.78 | 11.91 | 0.7746 | 12.88 | 8.47 | 1,918,640.00 | 17.22 | 1.83 | 27.23 | 2.58 | 31.25 | 20.65 | 22.23 | 4.15 | 1.30 | 13.68 | 0.4298 | -- | 81.88 | 27.08 | 421.05 | 27.71 | -19.49 | -- |
| Arkema SA | 75.75bn | 11.15bn | 61.83bn | 20.20k | 5.73 | 1.22 | 3.96 | 0.8162 | 19.52 | 19.52 | 133.34 | 91.43 | 0.8319 | 6.11 | 6.31 | 527,324.50 | 12.36 | 6.63 | 15.12 | 8.07 | 23.95 | 21.78 | 14.85 | 7.98 | 1.31 | 26.21 | 0.3238 | 27.67 | 20.74 | 4.79 | 325.33 | 24.81 | 9.62 | 7.91 |
| Chr Hansen Holding A/S | 8.52bn | 1.65bn | 68.96bn | 3.95k | 42.04 | 5.64 | 28.61 | 8.09 | 12.44 | 48.23 | 64.45 | 92.71 | 0.3592 | 3.46 | 6.92 | 2,159,963.00 | 6.94 | 10.12 | 8.86 | 12.73 | 56.50 | 57.40 | 19.31 | 21.61 | 0.6974 | 11.42 | 0.3764 | 61.35 | 11.07 | 2.57 | -14.21 | 1.57 | 14.83 | 20.14 |
| Umicore SA | 179.00bn | 4.61bn | 74.57bn | 13.64k | 15.90 | 3.15 | 10.38 | 0.4166 | 2.56 | 2.56 | 99.41 | 12.91 | 2.77 | 8.05 | 13.71 | 1,763,651.00 | 7.21 | 4.89 | 12.03 | 8.12 | 6.47 | 6.51 | 2.61 | 1.84 | 0.8833 | 12.69 | 0.4049 | 35.61 | 16.15 | 18.16 | 374.19 | 27.87 | 7.67 | 3.83 |
| Akron PAO | 19.43bn | 6.62bn | 78.85bn | 11.21k | 11.44 | 7.46 | 9.79 | 4.06 | 1,562.54 | 1,562.54 | 4,595.30 | 2,395.29 | 0.7354 | 2.99 | 21.09 | -- | 25.34 | 8.40 | 35.98 | 12.17 | 59.90 | 47.34 | 34.46 | 15.83 | 1.10 | -- | 0.4489 | 81.99 | 4.38 | 5.43 | -86.33 | -26.95 | 3.50 | -19.73 |
| Brenntag SE | 117.45bn | 4.47bn | 80.66bn | 17.21k | 18.06 | 2.55 | 11.46 | 0.6868 | 3.89 | 3.89 | 102.20 | 27.56 | 1.59 | 8.36 | 6.67 | 915,705.50 | 6.21 | 5.51 | 9.31 | 7.66 | 23.14 | 22.24 | 3.90 | 3.52 | 0.9808 | 13.04 | 0.3981 | 41.72 | 21.94 | 6.50 | -3.90 | 4.47 | 7.50 | 6.67 |
| Yara International ASA | 136.54bn | 9.71bn | 87.58bn | 17.80k | 9.05 | 1.54 | 5.40 | 0.6415 | 52.53 | 52.53 | 739.69 | 309.49 | 1.12 | 4.23 | 8.56 | 10,605,060.00 | 7.57 | 2.81 | 10.32 | 3.57 | 27.13 | 26.57 | 6.78 | 3.50 | 0.7444 | -- | 0.3365 | 150.29 | 43.36 | 7.93 | -35.02 | -9.93 | -12.00 | 23.39 |
| Evonik Industries AG | 119.77bn | 6.46bn | 87.83bn | 33.15k | 13.63 | 1.16 | 6.14 | 0.7334 | 1.86 | 1.87 | 34.52 | 21.84 | 0.7232 | 4.87 | 7.92 | 487,668.20 | 3.99 | 3.35 | 4.97 | 4.01 | 26.47 | 28.76 | 5.52 | 5.13 | 0.8003 | 29.42 | 0.2889 | 79.08 | 22.59 | 3.27 | 52.97 | 0.00 | -1.54 | 0.3454 |
| Novozymes A/S | 15.55bn | 3.09bn | 99.67bn | 6.64k | 39.70 | 10.75 | 21.97 | 6.41 | 11.05 | 11.05 | 55.54 | 40.79 | 0.6621 | 2.42 | 4.89 | 2,513,907.00 | 13.20 | 15.36 | 17.93 | 20.13 | 56.95 | 57.03 | 19.93 | 21.41 | 0.7552 | 19.29 | 0.3864 | 46.70 | 6.70 | 1.12 | 11.36 | 0.6217 | 0.3917 | 6.58 |
Data as of May 23 2022. Currency figures normalised to Chr Hansen Holding A/S's reporting currency: Danish Krone DKK
18.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| APG Asset Management NVas of 31 Aug 2021 | 6.61m | 5.01% |
| Baillie Gifford & Co.as of 19 May 2022 | 2.85m | 2.16% |
| The Vanguard Group, Inc.as of 05 May 2022 | 2.67m | 2.03% |
| Walter Scott & Partners Ltd.as of 31 Mar 2022 | 2.28m | 1.73% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 2.04m | 1.55% |
| BlackRock Fund Advisorsas of 04 May 2022 | 1.89m | 1.43% |
| Morgan Stanley Investment Management Co.as of 30 Apr 2022 | 1.73m | 1.32% |
| GuardCap Asset Management Ltd.as of 31 Mar 2022 | 1.69m | 1.28% |
| Morgan Stanley Investment Management, Inc.as of 30 Apr 2022 | 1.56m | 1.18% |
| Impax Asset Management Ltd.as of 31 Mar 2022 | 1.55m | 1.18% |
More ▼
Data from 31 Dec 2021 - 31 Mar 2022Source: FactSet Research Systems Inc.
